Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AlphaScreen Anti-6His Donor Beads, 1 mg
AlphaScreen Anti-6His Donor Beads, 1 mg
Alpha Donor beads conjugated to anti-6XHis antibody. This bead can be used to capture 6XHis-tagged proteins for Alpha no-wash protein-protein interaction assays and other applications.
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
Alpha Donor beads conjugated to anti-6XHis antibody. This bead can be used to capture 6XHis-tagged proteins for Alpha no-wash protein-protein interaction assays and other applications.
AlphaScreen Anti-6His Donor Beads, 1 mg
AlphaScreen Anti-6His Donor Beads, 1 mg
Product information
Overview
Alpha Donor beads conjugated to anti-6XHis antibody. The mouse monoclonal antibody detects proteins containing accessible consecutive histidine residues at the amino or carboxy terminus. These beads can be used to capture 6XHis-tagged antibodies, proteins and peptides, and can be used in conjunction with AlphaScreen, AlphaLISA, or AlphaPlex Acceptor beads to create no-wash assays for:
- Analyte detection assays
- Protein-protein interaction assays
- Protein-DNA interaction assays
- Protein-RNA interaction assays
- Protein-small molecule interaction assays
- Protein detection assays
- Enzymatic assays
In a typical Alpha assay, 1 mg of Donor beads is sufficient to run 1,000-2,000 wells using a 25 µL reaction volume. Bead concentration can be adjusted for optimal performance.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Automation Compatible |
Yes
|
| Bead Type or Material |
Alpha Donor
|
| Brand |
AlphaLISA
|
| Detection Modality |
Alpha
|
| Product Group |
Beads
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target Class |
Binding Assay
|
| Technology |
Alpha
|
| Unit Size |
1 mg
|
Video gallery
AlphaScreen Anti-6His Donor Beads, 1 mg
AlphaScreen Anti-6His Donor Beads, 1 mg
Citations
Resources
Are you looking for resources, click on the resource type to explore further.
Due to limitations driven by circulatory half-life and drug target bioavailability, injected biologics often require the injection...
How can we help you?
We are here to answer your questions.
